Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia (vol 97, pg 1889, 2018)

被引：0

作者：

Tiede, Andreas ^{[1
]}

Worster, Andrew ^{[2
]}

机构：

[1] Hannover Med Sch, Dept Haematol Haemostasis Oncol & Stem Cell Trans, Hannover, Germany

[2] McMaster Univ, Div Emergency Med, Hamilton, ON, Canada

来源：

ANNALS OF HEMATOLOGY | 2018年 / 97卷 / 12期

关键词：

D O I：

10.1007/s00277-018-3504-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The article Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia, written by Andreas Tiede and Andrew Worster, was originally published electronically on the publisher's internet portal (currently SpringerLink) on 26 May 2018 without open access.

引用

页码：2531 / 2531

页数：1

共 50 条

[1] Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia
Tiede, Andreas
Worster, Andrew
[J]. ANNALS OF HEMATOLOGY, 2018, 97 (10) : 1889 - 1901
[2] Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia
Andreas Tiede
Andrew Worster
[J]. Annals of Hematology, 2018, 97 : 1889 - 1901
[3] Correction to: Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia
Andreas Tiede
Andrew Worster
[J]. Annals of Hematology, 2018, 97 : 2531 - 2531
[4] CLASSIFICATION OF RECOMBINANT FACTOR VIII PRODUCTS IN HAEMOPHILIA A: A SYSTEMATIC LITERATURE REVIEW
Ay, C.
Napolitano, M.
Hassoun, A.
Tomic, R.
Martin, C.
Seifert, W.
Pinachyan, K.
Oldenburg, J.
[J]. HAEMOPHILIA, 2023, 29 : 44 - 45
[5] Methodologies for data collection in congenital haemophilia with inhibitors (CHwI): critical assessment of the literature and lessons learned from recombinant factor VIIa
Kessler, C. M.
el Fegoun, S. Benchikh
Worster, A.
[J]. HAEMOPHILIA, 2018, 24 (04) : 536 - 547
[6] USE OF RECOMBINANT FACTOR VIIA (RVIIA) IN GLANZMANN THROMBASTHENIA: A SYSTEMATIC REVIEW OF THE LITERATURE
Samelson-Jones, Ben J.
Lambert, Michele P.
[J]. AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E22 - E22
[7] Recombinant Factor VIIa (Eptacog Alfa)A Review of its Use in Congenital or Acquired Haemophilia and Other Congenital Bleeding Disorders
M. Asif A. Siddiqui
Lesley J. Scott
[J]. Drugs, 2005, 65 : 1161 - 1177
[8] Recombinant factor VIIa (Eptacog alfa) - A review of its use in congenital or acquired haemophilia and other congenital bleeding disorders
Siddiqui, MAA
Scott, LJ
[J]. DRUGS, 2005, 65 (08) : 1161 - 1177
[9] Efficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitors (vol 8, pg 649, 2002)
Mauser-Bunschoten, EP
Koopman, MMW
Goede-Bolder, ADE
Leebeek, FWG
van der Meer, J
Kooij, GMV
van der Linden, PWG
[J]. HAEMOPHILIA, 2002, 8 (06) : 835 - 835
[10] Phonics: reading policy and the evidence of effectiveness from a systematic 'tertiary' review (vol 34, pg 208, 2018)
Torgerson, Carole
Brooks, Greg
Gascoine, Louise
Higgins, Steve
[J]. RESEARCH PAPERS IN EDUCATION, 2019, 34 (03) : 389 - 389

← 1 2 3 4 5 →